scholarly article | Q13442814 |
P50 | author | Tasanee Braithwaite | Q58146567 |
Melanie Calvert | Q66764538 | ||
Konrad Pesudovs | Q37393333 | ||
P2093 | author name string | Alastair Gray | |
Alastair K Denniston | |||
P2860 | cites work | Interventions for idiopathic intracranial hypertension | Q24187976 |
The Health Utilities Index (HUI): concepts, measurement properties and applications | Q24616711 | ||
The MOS 36-ltem Short-Form Health Survey (SF-36) | Q26778425 | ||
Patient reported outcome measures for visual impairment after stroke: a systematic review | Q26786802 | ||
Heterogeneity of primary outcome measures used in clinical trials of treatments for intermediate, posterior, and panuveitis | Q26796779 | ||
EuroQol--a new facility for the measurement of health-related quality of life | Q29547873 | ||
Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance | Q29615569 | ||
First use of patient reported outcomes measurement information system (PROMIS) measures in adults with neurofibromatosis. | Q47864785 | ||
Patient reported outcome measures in practice | Q48049891 | ||
Patient-reported outcomes: comprehensive analysis for the oculofacial clinician | Q48076927 | ||
Visual function after correction of distance refractive error with ready-made and custom spectacles: a randomized clinical trial | Q48427558 | ||
Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols: The SPIRIT-PRO Extension. | Q48504041 | ||
A head-to-head comparison of 16 cataract surgery outcome questionnaires. | Q48585393 | ||
Changes in vision- and health-related quality of life in patients with diabetic macular edema treated with pegaptanib sodium or sham. | Q48597137 | ||
Remediating serious flaws in the National Eye Institute Visual Function Questionnaire. | Q48818550 | ||
Cataract surgery patient-reported outcome measures: a head-to-head comparison of the psychometric performance and patient acceptability of the Cat-PROM5 and Catquest-9SF self-report questionnaires. | Q49543360 | ||
Assessing health-related quality of life in primary Sjögren's syndrome-The PSS-QoL. | Q50209342 | ||
Deriving a preference-based single index from the UK SF-36 Health Survey. | Q52231497 | ||
Patient reported outcome measures in rare diseases: a narrative review. | Q52567035 | ||
Responsiveness and clinically important differences for the VF-14 index, SF-36, and visual acuity in patients undergoing cataract surgery. | Q53117303 | ||
Measuring outcomes of cataract surgery using the Visual Function Index-14. | Q53465429 | ||
Exploring the quality of life issues in people with retinal diseases: a qualitative study | Q56551827 | ||
Patient-derived questionnaire items for patient-reported outcome measures in pediatric eye conditions | Q57154004 | ||
Constructing Item Banks for Measuring Quality of Life in Refractive Error | Q57178796 | ||
Usage of glaucoma-specific patient-reported outcome measures (PROMs) in the Singapore context: a qualitative scoping exercise | Q58782414 | ||
A comparison of the EQ-5D and SF-6D across seven patient groups | Q60629828 | ||
Moving forward toward standardizing analysis of quality of life data in randomized cancer clinical trials | Q61821561 | ||
MACUSTAR: Development and Clinical Validation of Functional, Structural, and Patient-Reported Endpoints in Intermediate Age-Related Macular Degeneration | Q61910897 | ||
Developing an item bank to measure the coping strategies of people with hereditary retinal diseases | Q62602379 | ||
Questionnaire-based survey on the importance of quality of life measures in ophthalmic practice | Q74616547 | ||
Validation and test characteristics of a 10-item neuro-ophthalmic supplement to the NEI-VFQ-25 | Q79259326 | ||
Effects of clinical parameters on patient-reported outcome in cataract patients: a multicentre study | Q88163906 | ||
A Systematic Review of Patient-Reported Outcomes for Surgically Amenable Epiphora | Q88602989 | ||
Development of a New Module of the FACE-Q for Children and Young Adults with Diverse Conditions Associated with Visible and/or Functional Facial Differences | Q89106121 | ||
Shared Cared for Stable Glaucoma Patients: Economic Benefits and Patient-centered Outcomes of a Feasibility Trial | Q89720876 | ||
The Glaucoma Intensive Treatment Study (GITS), a randomized clinical trial: design, methodology and baseline data | Q91255988 | ||
Assessment of patient-reported outcomes in retinal diseases: a systematic review | Q39071064 | ||
Questionnaires for Measuring Refractive Surgery Outcomes | Q39354294 | ||
Reducing respondent burden: validation of the Brief Impact of Vision Impairment questionnaire | Q39455798 | ||
Modeling valuations for EuroQol health states | Q39513119 | ||
Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial. A multicentre, randomised controlled trial: design and methodology | Q40042636 | ||
Association Between Visual Function Response and Reduction of Inflammation in Noninfectious Uveitis of the Posterior Segment | Q40131902 | ||
Quality-of-Life Outcomes From a Randomized Clinical Trial Comparing Antimetabolites for Intermediate, Posterior, and Panuveitis | Q40240534 | ||
The estimation of a preference-based measure of health from the SF-36. | Q40647897 | ||
Assessment of the Incorporation of Patient-Centric Outcomes in Studies of Minimally Invasive Glaucoma Surgical Devices | Q40662423 | ||
Assessing the impact of healthcare research: A systematic review of methodological frameworks. | Q41326448 | ||
Using classical test theory, item response theory, and Rasch measurement theory to evaluate patient-reported outcome measures: a comparison of worked examples | Q41572927 | ||
Vision-related function after ranibizumab treatment by better- or worse-seeing eye: clinical trial results from MARINA and ANCHOR. | Q43147357 | ||
Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries | Q44190751 | ||
A study of the correlation between patient-reported outcomes and clinical outcomes after cataract surgery in ophthalmic clinics | Q44449751 | ||
The routine use of patient reported outcome measures in healthcare settings. | Q45933032 | ||
Improved vision-related function after ranibizumab for macular edema after retinal vein occlusion: results from the BRAVO and CRUISE trials | Q46397226 | ||
SCORE2 Report 5: Vision-Related Function in Patients With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion | Q46777540 | ||
COSUMO: study protocol for the development of a core outcome set for efficacy and effectiveness trials in posterior segment-involving uveitis | Q47107888 | ||
Mapping standard ophthalmic outcome sets to metrics currently reported in eight eye hospitals | Q47124216 | ||
Treatment of Advanced Glaucoma Study: a multicentre randomised controlled trial comparing primary medical treatment with primary trabeculectomy for people with newly diagnosed advanced glaucoma-study protocol. | Q47232823 | ||
Diabetic Retinopathy and Macular Edema Quality-of-Life Item Banks: Development and Initial Evaluation Using Computerized Adaptive Testing | Q47547743 | ||
Quality of Life in the Tube Versus Trabeculectomy Study | Q47579358 | ||
Glaucoma Australia educational impact study: a randomized short-term clinical trial evaluating the association between glaucoma education and patient knowledge, anxiety and treatment satisfaction. | Q47832680 | ||
Preference-based quality of life measures in people with visual impairment | Q36911016 | ||
Challenges in the design and implementation of the Multicenter Uveitis Steroid Treatment (MUST) Trial--lessons for comparative effectiveness trials | Q37205804 | ||
Patient-reported outcome measure for neuromyelitis optica: pretesting of preliminary instrument and protocol for further development in accordance with international guidelines | Q37312209 | ||
Development of a patient-centred conceptual framework of health-related quality of life in neuromyelitis optica: a qualitative study | Q37567603 | ||
FACE-Q Eye Module for Measuring Patient-Reported Outcomes Following Cosmetic Eye Treatments | Q37594832 | ||
Item banking: a generational change in patient-reported outcome measurement | Q37689472 | ||
Health-related quality of life, visual function and treatment satisfaction following intravitreal dexamethasone implant for diabetic macular edema | Q37718835 | ||
The impact of diabetic retinopathy: understanding the patient's perspective | Q37799680 | ||
Choosing appropriate patient-reported outcomes instrument for glaucoma research: a systematic review of vision instruments. | Q37825805 | ||
Utility values in National Institute for Health and Clinical Excellence (NICE) Technology Appraisals | Q37826471 | ||
Questionnaires for measuring cataract surgery outcomes | Q37867775 | ||
Social and emotional impact of diabetic retinopathy: a review | Q37875909 | ||
Proposed outcome measures for prospective clinical trials in juvenile idiopathic arthritis-associated uveitis: a consensus effort from the multinational interdisciplinary working group for uveitis in childhood. | Q37995987 | ||
Appraisal of patient-reported outcome instruments available for randomized clinical trials in dry eye: revisiting the standards | Q38000626 | ||
Patient-reported outcome measures (PROMs) in paediatric ophthalmology: a systematic review | Q38112550 | ||
Quality assessment of ophthalmic questionnaires: review and recommendations | Q38123064 | ||
Effect of Adalimumab on Visual Functioning in Patients With Noninfectious Intermediate Uveitis, Posterior Uveitis, and Panuveitis in the VISUAL-1 and VISUAL-2 Trials | Q38377748 | ||
Outcomes of the Veterans Affairs Low Vision Intervention Trial II (LOVIT II): A Randomized Clinical Trial | Q38383461 | ||
Outcomes of the Veterans Affairs Low Vision Intervention Trial (LOVIT). | Q38390326 | ||
A randomized clinical trial of intravitreal bevacizumab versus intravitreal dexamethasone for diabetic macular edema: the BEVORDEX study. | Q38424909 | ||
Normative comparison of patient-reported outcomes in patients with noninfectious uveitis | Q38456029 | ||
A Proposed Minimum Standard Set of Outcome Measures for Cataract Surgery | Q38570182 | ||
Valuing health-related quality of life: An EQ-5D-5L value set for England. | Q38611896 | ||
Development of a new Rasch-based scoring algorithm for the National Eye Institute Visual Functioning Questionnaire to improve its interpretability | Q38625482 | ||
Validation of Catquest-9SF-A Visual Disability Instrument to Evaluate Patient Function After Corneal Transplantation | Q38640661 | ||
Patient-reported outcome measures in amblyopia and strabismus: a systematic review | Q38668555 | ||
"The patient is speaking": discovering the patient voice in ophthalmology | Q38689548 | ||
Developing a Core Set of Outcome Measures for Behçet Disease: Report from OMERACT 2016. | Q38736648 | ||
Defining a Minimum Set of Standardized Patient-centered Outcome Measures for Macular Degeneration | Q38821840 | ||
Patient-Centered Outcome Measures to Assess Functioning in Randomized Controlled Trials of Low-Vision Rehabilitation: A Review | Q38834070 | ||
Health-related Quality of Life of Individuals With Neurofibromatosis Type 2: Results From the NF2 Natural History Study. | Q38885011 | ||
A randomised controlled trial to assess the clinical effectiveness and cost-effectiveness of alternative treatments to Inhibit VEGF in Age-related choroidal Neovascularisation (IVAN). | Q38955591 | ||
One size doesn't fit all: time to revisit patient-reported outcome measures (PROMs) in paediatric ophthalmology? | Q30239025 | ||
Health State Utility Values for Age-Related Macular Degeneration: Review and Advice. | Q30393038 | ||
Quality of life after first- and second-eye cataract surgery: five-year data collected by the Swedish National Cataract Register | Q30664737 | ||
Patient-centred measurement in ophthalmology--a paradigm shift | Q33246797 | ||
The impact of diabetic retinopathy on quality of life: qualitative findings from an item bank development project | Q33454384 | ||
Evaluation of item candidates for a diabetic retinopathy quality of life item bank | Q33455212 | ||
Identifying content for the glaucoma-specific item bank to measure quality-of-life parameters | Q33455522 | ||
Methods to Develop the Eye-tem Bank to Measure Ophthalmic Quality of Life | Q33458601 | ||
The COSMIN checklist for evaluating the methodological quality of studies on measurement properties: a clarification of its content | Q33542834 | ||
Measurement of health state utilities for economic appraisal | Q33628526 | ||
Emerging Use of Early Health Technology Assessment in Medical Product Development: A Scoping Review of the Literature | Q33845622 | ||
Subscale assessment of the NEI-RQL-42 questionnaire with Rasch analysis. | Q33933886 | ||
Patients' perceptions of the value of current vision: assessment of preference values among patients with subfoveal choroidal neovascularization--The Submacular Surgery Trials Vision Preference Value Scale: SST Report No. 6 | Q34081875 | ||
Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). | Q34177200 | ||
Visual function assessment questionnaires | Q34293016 | ||
The measurement of vision disability | Q34801205 | ||
An exploratory study to test the impact on three "bolt-on" items to the EQ-5D. | Q35024619 | ||
Patient-reported outcomes (PRO's) in glaucoma: a systematic review | Q35208797 | ||
Vision-related function after ranibizumab treatment for diabetic macular edema: results from RIDE and RISE. | Q35230022 | ||
Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease | Q35592019 | ||
Patient-reported outcomes in randomised controlled trials on age-related macular degeneration. | Q35620796 | ||
Three-year patient-reported visual function outcomes in diabetic macular edema managed with ranibizumab: the RESTORE extension study | Q35761067 | ||
Comparing the effectiveness of selective laser trabeculoplasty with topical medication as initial treatment (the Glaucoma Initial Treatment Study): study protocol for a randomised controlled trial | Q35771380 | ||
Psychometric properties of vision-related quality of life questionnaires: a systematic review | Q35823559 | ||
Randomised, single-masked non-inferiority trial of femtosecond laser-assisted versus manual phacoemulsification cataract surgery for adults with visually significant cataract: the FACT trial protocol | Q35854753 | ||
Severe Health-Related Quality of Life Impairment in Active Primary Sjögren's Syndrome and Patient-Reported Outcomes: Data From a Large Therapeutic Trial | Q36070691 | ||
Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. | Q36235355 | ||
It's more than dryness and fatigue: The patient perspective on health-related quality of life in Primary Sjögren's Syndrome - A qualitative study | Q36275817 | ||
Evaluation of the Adult Strabismus-20 (AS-20) questionnaire using Rasch analysis | Q36390580 | ||
Quality criteria were proposed for measurement properties of health status questionnaires | Q36680196 | ||
Incorporating Health-related Quality of Life Into the Assessment of Outcome Following Strabismus Surgery | Q36739693 | ||
Effects of Prior Intensive Insulin Therapy and Risk Factors on Patient-Reported Visual Function Outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Cohort | Q36781299 | ||
The development, assessment, and selection of questionnaires | Q36911008 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | eye disease | Q3041498 |
Randomized Controlled Trials | Q56855364 | ||
P304 | page(s) | 9-24 | |
P577 | publication date | 2019-01-01 | |
P1433 | published in | Patient Related Outcome Measures | Q15816474 |
P1476 | title | The use of patient-reported outcome research in modern ophthalmology: impact on clinical trials and routine clinical practice | |
P478 | volume | 10 |
Q91330075 | Advanced glaucoma at diagnosis: current perspectives |
Q99720040 | Catquest-9SF questionnaire and eCAPS: Validation in a Canadian population |
Q92691394 | Cochrane corner: why we still don't know whether anti-TNF biologic therapies impact uveitic macular oedema |
Q96132487 | Development and Validation of the "Keratoconus End-Points Assessment Questionnaire" (KEPAQ), a Disease-Specific Instrument for Evaluating Subjective Emotional Distress and Visual Function Through Rasch Analysis |
Q99636426 | Eye health and quality of life: an umbrella review protocol |
Q91942736 | Patient-reported data informing early benefit assessment of rare diseases in Germany: A systematic review |
Q89889178 | Patient-reported outcome measures in inherited retinal degeneration gene therapy trials |
Q90570063 | Vision Loss from Atypical Optic Neuritis: Patient and Physician Perspectives |
Search more.